ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements with these filters
H1 FY27 PAT doubled to ₹273 Cr; GWP up 26% ex-1/n. Loss ratio gains credited to mix; management declined to quantify drivers. Solvency drifting down to 2.03x is the watch item.
Niva Bupa reported Q2 FY27 PAT of ₹136 crore, up 124%, and GWP of ₹2,484 crore, up 35%. The release highlights strong Retail Health growth and an improved solvency ratio.
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
H1 FY27 GWP ₹4,634 Cr (+33.4% y-o-y, 1/n basis); PAT ₹273.4 Cr, more than doubled; CISR improved to 99.5% from 103.1%; retail health share 11.0%.
Niva Bupa Health Insurance's Board approved the amendment and consolidation of its UPSI Fair Disclosure and Leak Inquiry policies. The integrated policy streamlines operational compliance under SEBI PIT Regulations.
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,572 Cr (+25.5% YoY) and net profit of ₹135.6 Cr (+124.1% YoY) for Q2 FY27.
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Niva Bupa Health Insurance Company Limited announced the sad demise of Mr. Roger William John Davis, a Non-Executive Non-Independent Director, effective October 17, 2026.
Niva Bupa Health Insurance announced the sad demise of Non-Executive Director Mr. Roger William John Davis, effective October 17, 2026.
Niva Bupa Health Insurance received a credit rating of IND AAA/Stable for its proposed subordinated debt issuance. This rating reflects the company's proposed debt instrument.
Niva Bupa Health Insurance will exercise its call option to redeem 1,500 non-convertible debentures on November 15, 2026, for a total principal amount of ₹150 Crore.
Niva Bupa Health Insurance will hold a committee meeting on 09-Oct-2026 to consider altering the payment date for interest or redemption amounts on debt securities.
Niva Bupa Health Insurance will hold a Debt Raising Committee meeting on October 9, 2026, to approve the redemption of NCDs aggregating to ₹150 Crore.
Niva Bupa Health Insurance received credit ratings from AM Best, including a Financial Strength Rating of A- and Long-Term Issuer Credit Rating of a-.
Niva Bupa Health Insurance announced that Mr. Vikas Jain transitioned to Chief Transformation Officer, while Mr. Karan Bhatia was appointed as the new Chief Investment Officer.
Niva Bupa received an ESG rating of '67 Leader' for FY24-25 and FY25-26 from Niche99. The rating was assigned independently by the SEBI-registered provider without company engagement.
Niva Bupa Health Insurance allotted 4,11,000 equity shares to employees under its ESOP schemes, increasing the company's total paid-up share capital.
Niva Bupa Health Insurance received credit rating actions from ICRA, reaffirming its Issuer Rating and assigning a rating to its proposed ₹500 crore subordinated debt issue.
IRDAI warned Niva Bupa for non-compliance with Expense of Management limits. The regulator prohibited the company from opening new business locations for six months.
Niva Bupa Health Insurance held its 18th Annual General Meeting on August 12, 2026, to discuss business performance and approve key director appointments and remunerations.
Niva Bupa Health Insurance Company Limited received IRDAI approval for appointing Mr. Ashwani Bhatia as Chairperson. The appointment is effective retrospectively from June 03, 2026.
Niva Bupa reported strong Q1 FY27 results with 31.7% reported growth and PAT improving to INR 137.8 crores. Management focused on retail health expansion and transition to Ind AS accounting.
Niva Bupa Health Insurance's board approved raising up to ₹500 Crore via debt securities. A Debt Raising Committee was formed to finalize terms.
Niva Bupa Health Insurance reported a 93% YoY growth in PAT to ₹138 crore, with a Gross Written Premium of ₹2,150 crore for Q1 FY2026.
Niva Bupa reported strong Q1’FY2027 performance with GWP growing 31.7% and PAT nearly doubling to ₹137.8 crore, driven by retail health market share expansion to 11.1% and improved underwriting discipline.
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,274 Cr (+28.6% YoY) and net profit of ₹137.8 Cr (+93.0% YoY) for Q1 FY27.
Niva Bupa Health Insurance will hold a board meeting on July 30, 2026, to consider quarterly financial results and potential debt-based fund raising.
Niva Bupa Health Insurance filed its quarterly shareholding pattern for the period ended June 30, 2026. The filing discloses changes within the promoter group structure.
Niva Bupa Health Insurance Company Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG and governance frameworks.